Par Health USA, LLC recalls

3 recalls in our records from 2026 to 2026: 3 FDA drugs.

Recalls with full detail pages

• FDA · DrugsClass IOct 28, 2026

  Par Health USA, LLC drug recall: Argatroban Injection

  Particulate matter: particulate matter identified as cellulose, polystyrene, polyethylene teraphalate, stainless steel, or stopper material in the product solution.

Earlier and other recalls

These link to the official agency notice.

• FDA · DrugsClass IIOct 7, 2026

  Par Health USA, LLC drug recall: Buprenorphine Hydrochloride Official notice ↗

  Crystallization

• FDA · DrugsClass IIJun 24, 2026

  Par Health USA, LLC drug recall: Buprenorphine HCl Official notice ↗

  Crystallization; identified as Buprenorphine free base

Firm names are matched across agencies by name only. Different companies with similar names may be grouped together; check each official notice.